2025 annual financial data
TScan Therapeutics 2025 Net margin
Direct answer
Net margin was -1,256.81%.
Operating income was -135.81M USD and net income was -129.77M USD.
Operating cash flow was -135.32M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10.33M USD
- Operating income
- -135.81M USD
- Net income
- -129.77M USD
- Operating cash flow
- -135.32M USD